Skip to main content
Top
Published in: Journal of Nephrology 1/2016

01-02-2016 | Original Article

Serum biomarkers in uncontrolled no heart-beating donors may identify kidneys that will never work after transplantation

Authors: Antonio J. López-Farré, Juana María Santos-Sancho, Javier Modrego, Antonio Segura, José J. Zamorano-León, Leyre Martín, Ana Sánchez-Fructuoso, Pablo Rodríguez-Sierra, Fernando Prados, Alonso Mateos, José Herrero, Francisco del Río, Alberto Barrientos

Published in: Journal of Nephrology | Issue 1/2016

Login to get access

Abstract

Background/aims

Kidneys from uncontrolled non heart-beating donors achieve a good level of renal function after transplantation. However, a number of them will never function in the recipient. Our aim was to determine if serum biomarkers associated with platelet activity, inflammation and the nitric oxide system in uncontrolled non heart-beating donors may help to predict no renal function recovery after renal transplantation.

Methods

Serum levels of interleukin (IL)-6, IL-10, intercellular cell adhesion molecule-1 (ICAM-1), cyclic guanosine monophosphate (cGMP), nitrite + nitrate and platelet factor-4 (PF4) were measured using enzyme-linked immunosorbent assay (ELISA) kits in 88 uncontrolled non heart-beating donors divided according to the renal functionality achieved in the recipients into functional (n = 76) and non functional (n = 12).

Results

Kidneys from donors with higher IL-6 levels (>900 pg/ml) were functional after transplantation. Serum cGMP levels below 372.3 fmol/l were also associated with kidneys that recovered the renal function. However, serum levels of PF4 showed the best correlation with recovery of renal functional in the recipients since they were significantly lower in the donors whose kidneys functioned after transplantation.

Conclusions

Serum PF4 levels in uncontrolled non heart-beating donors may be a good predictor for kidneys that never will reach functional recovery. Some serum cGMP, IL-6 and IL-10 levels may simply help identify kidneys that will function after transplantation.
Literature
1.
go back to reference Gerstenkorn C (2003) Non-heart-beating donors: renewed source of organs for renal transplantation during the twenty-first century. World J Surg 27:489–493PubMedCrossRef Gerstenkorn C (2003) Non-heart-beating donors: renewed source of organs for renal transplantation during the twenty-first century. World J Surg 27:489–493PubMedCrossRef
2.
go back to reference Kootstra G, Daemen JH, Oomen AP (1995) Categories of non-heart-beating donors. Transplant Proc 27:2893–2894PubMed Kootstra G, Daemen JH, Oomen AP (1995) Categories of non-heart-beating donors. Transplant Proc 27:2893–2894PubMed
3.
go back to reference Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF (2004) Survival following liver transplantation from non-heart-beating donors. Ann Surg 239:87–92PubMedPubMedCentralCrossRef Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF (2004) Survival following liver transplantation from non-heart-beating donors. Ann Surg 239:87–92PubMedPubMedCentralCrossRef
4.
go back to reference Sharif A, Borrows R (2013) Delayed graft function after kidney transplantation: the clinical perspective. Am J Kidney Dis 62:150–158PubMedCrossRef Sharif A, Borrows R (2013) Delayed graft function after kidney transplantation: the clinical perspective. Am J Kidney Dis 62:150–158PubMedCrossRef
5.
go back to reference Schlumpf R, Candinas D, Weder W, Röthlin M, Zollinger A, Bleisch J, Retsch M, Largiadèr F (1993) Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: associated with secondary grafts and early cyclosporine treatment? Transplant Proc 25:1518–1521PubMed Schlumpf R, Candinas D, Weder W, Röthlin M, Zollinger A, Bleisch J, Retsch M, Largiadèr F (1993) Acute vascular rejection with hemolytic uremic syndrome in kidneys from non-heart-beating donors: associated with secondary grafts and early cyclosporine treatment? Transplant Proc 25:1518–1521PubMed
6.
go back to reference Zarifian A, Meleg-Smith S, O’donovan R, Tesi RJ, Batuman V (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 55:2457–2466PubMedCrossRef Zarifian A, Meleg-Smith S, O’donovan R, Tesi RJ, Batuman V (1999) Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 55:2457–2466PubMedCrossRef
7.
go back to reference Noris M, Remuzzi G (2010) Thrombotic microangiopathy after kidney transplantation. Am J Transplant 10:1517–1523PubMedCrossRef Noris M, Remuzzi G (2010) Thrombotic microangiopathy after kidney transplantation. Am J Transplant 10:1517–1523PubMedCrossRef
8.
go back to reference Sánchez-Fructuoso AI, Prats D, Torrente J, Pérez-Contín MJ, Fernández C, Alvarez J, Barrientos A (2000) Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol 11:350–358PubMed Sánchez-Fructuoso AI, Prats D, Torrente J, Pérez-Contín MJ, Fernández C, Alvarez J, Barrientos A (2000) Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol 11:350–358PubMed
9.
go back to reference Coca SG, Yalavarthy R, Concato J, Parikh CR (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:1008–1016PubMedCrossRef Coca SG, Yalavarthy R, Concato J, Parikh CR (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:1008–1016PubMedCrossRef
10.
go back to reference Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M (2009) Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery–a prospective cohort study. Crit Care Med 37:553–560PubMedCrossRef Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Dragun D, Haase M (2009) Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery–a prospective cohort study. Crit Care Med 37:553–560PubMedCrossRef
11.
go back to reference Aidoudi S, Bikfalvi A (2010) Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thromb Haemost 104:941–948PubMedCrossRef Aidoudi S, Bikfalvi A (2010) Interaction of PF4 (CXCL4) with the vasculature: a role in atherosclerosis and angiogenesis. Thromb Haemost 104:941–948PubMedCrossRef
12.
13.
go back to reference Shao J, Miyata T, Yamada K, Hanafusa N, Wada T, Gordon KL, Inagi R, Kurokawa K, Fujita T, Johnson RJ, Nangaku M (2001) Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J Am Soc Nephrol 12:2088–2097PubMed Shao J, Miyata T, Yamada K, Hanafusa N, Wada T, Gordon KL, Inagi R, Kurokawa K, Fujita T, Johnson RJ, Nangaku M (2001) Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J Am Soc Nephrol 12:2088–2097PubMed
14.
go back to reference Sacristán D, López-Farré AJ, Zamorano-León JJ, Azcona L, Fernández-Ortiz A, Romero J, Farré J, Macaya C (2008) Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation. J Cardiovasc Pharmacol 51:286–292PubMedCrossRef Sacristán D, López-Farré AJ, Zamorano-León JJ, Azcona L, Fernández-Ortiz A, Romero J, Farré J, Macaya C (2008) Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation. J Cardiovasc Pharmacol 51:286–292PubMedCrossRef
15.
go back to reference López-Farré AJ, Modrego J, Azcona L, Guerra R, Segura A, Rodríguez P, Zamorano-León JJ, Lahera V, Macaya C (2014) Nitric oxide from mononuclear cells may be involved in platelet responsiveness to aspirin. Eur J Clin Invest 44:463–469PubMedCrossRef López-Farré AJ, Modrego J, Azcona L, Guerra R, Segura A, Rodríguez P, Zamorano-León JJ, Lahera V, Macaya C (2014) Nitric oxide from mononuclear cells may be involved in platelet responsiveness to aspirin. Eur J Clin Invest 44:463–469PubMedCrossRef
16.
go back to reference García-Cardoso J, Vela R, Mahillo E, Mateos-Cáceres PJ, Modrego J, Macaya C, López-Farré AJ (2010) Increased cyclic guanosine monophosphate production and endothelial nitric oxide synthase level in mononuclear cells from sildenafil citrate-treated patients with erectile dysfunction. Int J Impot Res 22:68–76PubMedCrossRef García-Cardoso J, Vela R, Mahillo E, Mateos-Cáceres PJ, Modrego J, Macaya C, López-Farré AJ (2010) Increased cyclic guanosine monophosphate production and endothelial nitric oxide synthase level in mononuclear cells from sildenafil citrate-treated patients with erectile dysfunction. Int J Impot Res 22:68–76PubMedCrossRef
17.
go back to reference Lauzurica R, Pastor MC, Bayés B, Hernandez JM, Bonet J, Doladé M, Navarro M, Romero R (2008) Pretransplant inflammation: a risk factor for delayed graft function? J Nephrol 21:221–228PubMed Lauzurica R, Pastor MC, Bayés B, Hernandez JM, Bonet J, Doladé M, Navarro M, Romero R (2008) Pretransplant inflammation: a risk factor for delayed graft function? J Nephrol 21:221–228PubMed
18.
go back to reference Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P (2003) Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 18:1042–1045PubMedCrossRef Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P (2003) Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 18:1042–1045PubMedCrossRef
19.
go back to reference Mikłaszewska M, Korohoda P, Zachwieja K, Mroczek T, Drożdż D, Sztefko K, Moczulska A, Pietrzyk JA (2013) Serum interleukin 6 levels as an early marker of acute kidney injury on children after cardiac surgery. Adv Clin Exp Med 22:377–386PubMed Mikłaszewska M, Korohoda P, Zachwieja K, Mroczek T, Drożdż D, Sztefko K, Moczulska A, Pietrzyk JA (2013) Serum interleukin 6 levels as an early marker of acute kidney injury on children after cardiac surgery. Adv Clin Exp Med 22:377–386PubMed
20.
go back to reference Jin Y, Liu R, Xie J, Xiong H, He JC, Chen N (2013) Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Invest 93:801–811PubMedCrossRef Jin Y, Liu R, Xie J, Xiong H, He JC, Chen N (2013) Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Invest 93:801–811PubMedCrossRef
21.
go back to reference Sancho A, Pastor MC, Bayés B, Sánchez A, Morales-Indiano C, Doladé M, Romero R, Lauzurica R (2010) Posttransplant inflammation associated with onset of chronic kidney disease. Transplant Proc 42:2896–2898PubMedCrossRef Sancho A, Pastor MC, Bayés B, Sánchez A, Morales-Indiano C, Doladé M, Romero R, Lauzurica R (2010) Posttransplant inflammation associated with onset of chronic kidney disease. Transplant Proc 42:2896–2898PubMedCrossRef
22.
go back to reference Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK (2003) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132:24–31PubMedPubMedCentralCrossRef Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jørgensen T, Pedersen BK (2003) Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol 132:24–31PubMedPubMedCentralCrossRef
23.
go back to reference Pazos P, Lima L, Casanueva FF, Diéguez C, García MC (2013) Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice. PLoS One 8:e72339PubMedPubMedCentralCrossRef Pazos P, Lima L, Casanueva FF, Diéguez C, García MC (2013) Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice. PLoS One 8:e72339PubMedPubMedCentralCrossRef
24.
go back to reference Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H (1988) Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 155:1459–1463PubMedCrossRef Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H (1988) Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 155:1459–1463PubMedCrossRef
25.
go back to reference Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV (1999) Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56:281–288PubMedCrossRef Sankaran D, Asderakis A, Ashraf S, Roberts IS, Short CD, Dyer PA, Sinnott PJ, Hutchinson IV (1999) Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 56:281–288PubMedCrossRef
26.
go back to reference Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Fung JJ, Starzl TE (1995) Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc 27:2898PubMed Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Fung JJ, Starzl TE (1995) Experience with liver and kidney allografts from non-heart-beating donors. Transplant Proc 27:2898PubMed
27.
go back to reference Freedman JE, Loscalzo J (2003) Nitric oxide and its relationship to thrombotic disorders. J Thromb Haemost 1:1183–1188PubMedCrossRef Freedman JE, Loscalzo J (2003) Nitric oxide and its relationship to thrombotic disorders. J Thromb Haemost 1:1183–1188PubMedCrossRef
28.
go back to reference Sethi S, Iida S, Sigmund CD, Heistad DD (2006) Renal thrombotic microangiopathy in a genetic model of hypertension in mice. Exp Biol Med (Maywood) 231:196–203 Sethi S, Iida S, Sigmund CD, Heistad DD (2006) Renal thrombotic microangiopathy in a genetic model of hypertension in mice. Exp Biol Med (Maywood) 231:196–203
29.
go back to reference Jakob G, Mair J, Vorderwinkler KP, Judmaier G, König P, Zwierzina H, Pichler M, Puschendorf B (1994) Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure. Clin Chem 40:96–100PubMed Jakob G, Mair J, Vorderwinkler KP, Judmaier G, König P, Zwierzina H, Pichler M, Puschendorf B (1994) Clinical significance of urinary cyclic guanosine monophosphate in diagnosis of heart failure. Clin Chem 40:96–100PubMed
30.
go back to reference Mair J, Puschendorf B (1998) Is measurement of cyclic guanosine monophosphate in plasma or urine suitable for assessing in vivo nitric oxide production? Circulation 31(97):1209–1210CrossRef Mair J, Puschendorf B (1998) Is measurement of cyclic guanosine monophosphate in plasma or urine suitable for assessing in vivo nitric oxide production? Circulation 31(97):1209–1210CrossRef
31.
go back to reference Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, Hoeper MM, Haller H, Fliser D (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 20:172–177CrossRef Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, Hoeper MM, Haller H, Fliser D (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 20:172–177CrossRef
32.
go back to reference Lew RA, Baertschi AJ (1989) Mechanisms of hypoxia-induced atrial natriuretic factor release from rat hearts. Am J Physiol 257:H147–H156PubMed Lew RA, Baertschi AJ (1989) Mechanisms of hypoxia-induced atrial natriuretic factor release from rat hearts. Am J Physiol 257:H147–H156PubMed
33.
go back to reference Anker SD, Coats AJ (1997) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 95:538–539PubMed Anker SD, Coats AJ (1997) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation 95:538–539PubMed
34.
go back to reference Dussaule JC, Ardaillou R (1990) Current indications of plasma atrial natriuretic peptide measurements in human diseases. Horm Res 34:133–137PubMedCrossRef Dussaule JC, Ardaillou R (1990) Current indications of plasma atrial natriuretic peptide measurements in human diseases. Horm Res 34:133–137PubMedCrossRef
35.
go back to reference Hamet P, Pang SC, Tremblay J (1989) natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem 264:12364–12369PubMed Hamet P, Pang SC, Tremblay J (1989) natriuretic factor-induced egression of cyclic guanosine 3′:5′-monophosphate in cultured vascular smooth muscle and endothelial cells. J Biol Chem 264:12364–12369PubMed
36.
go back to reference Mercapide J, Santiago E, Alberdi E, Martinez-Irujo JJ (1999) Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells. Biochem Pharmacol 58:1675–1683PubMedCrossRef Mercapide J, Santiago E, Alberdi E, Martinez-Irujo JJ (1999) Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells. Biochem Pharmacol 58:1675–1683PubMedCrossRef
37.
go back to reference Dell’anna AM, Bini Vinotti J, Beumier M, Orbegozo-Cortes D, Donatello K, Scolletta S, Vincent JL, Taccone FS (2014) C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia. Resucitation 85:932–938CrossRef Dell’anna AM, Bini Vinotti J, Beumier M, Orbegozo-Cortes D, Donatello K, Scolletta S, Vincent JL, Taccone FS (2014) C-reactive protein levels after cardiac arrest in patients treated with therapeutic hypothermia. Resucitation 85:932–938CrossRef
38.
go back to reference Levine SP, Lindenfeld J, Ellis JB, Raymond NM, Krentz LS (1981) Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion. Circulation 64:626–632PubMedCrossRef Levine SP, Lindenfeld J, Ellis JB, Raymond NM, Krentz LS (1981) Increased plasma concentrations of platelet factor 4 in coronary artery disease: a measure of in vivo platelet activation and secretion. Circulation 64:626–632PubMedCrossRef
39.
go back to reference Sachais BS, Higazi AA, Cines DB, Poncz M, Kowalska MA (2004) Interactions of platelet factor 4 with the vessel wall. Semin Thromb Hemost 30:351–358PubMedCrossRef Sachais BS, Higazi AA, Cines DB, Poncz M, Kowalska MA (2004) Interactions of platelet factor 4 with the vessel wall. Semin Thromb Hemost 30:351–358PubMedCrossRef
40.
go back to reference Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, Khalapyan TZ, Wolfe ML, Fairman R, Mitchell M, Carpenter J, Golden MA, Cines DB, Sachais BS (2003) Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 90:1112–1120PubMed Pitsilos S, Hunt J, Mohler ER, Prabhakar AM, Poncz M, Dawicki J, Khalapyan TZ, Wolfe ML, Fairman R, Mitchell M, Carpenter J, Golden MA, Cines DB, Sachais BS (2003) Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 90:1112–1120PubMed
41.
go back to reference Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, Ganz P, Kinlay S, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators (2013) Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2:e003103PubMedPubMedCentralCrossRef Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, Ganz P, Kinlay S, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators (2013) Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2:e003103PubMedPubMedCentralCrossRef
42.
go back to reference Tzoulaki I, Murray GD, Lee AJ, Rulmley A, Lowe GD, Fowkes FG (2005) C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112:976–983PubMedCrossRef Tzoulaki I, Murray GD, Lee AJ, Rulmley A, Lowe GD, Fowkes FG (2005) C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112:976–983PubMedCrossRef
43.
go back to reference Goldberg ID, Stemerman MB, Handin RI (1980) Vascular permeation of platelet factor 4 after endothelial injury. Science 209:611–612PubMedCrossRef Goldberg ID, Stemerman MB, Handin RI (1980) Vascular permeation of platelet factor 4 after endothelial injury. Science 209:611–612PubMedCrossRef
Metadata
Title
Serum biomarkers in uncontrolled no heart-beating donors may identify kidneys that will never work after transplantation
Authors
Antonio J. López-Farré
Juana María Santos-Sancho
Javier Modrego
Antonio Segura
José J. Zamorano-León
Leyre Martín
Ana Sánchez-Fructuoso
Pablo Rodríguez-Sierra
Fernando Prados
Alonso Mateos
José Herrero
Francisco del Río
Alberto Barrientos
Publication date
01-02-2016
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 1/2016
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-015-0203-3

Other articles of this Issue 1/2016

Journal of Nephrology 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.